|
1
|
Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification.
|
Cancer
|
2009
|
2.98
|
|
2
|
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.
|
Nat Genet
|
2013
|
2.83
|
|
3
|
Combination chemotherapy in advanced adrenocortical carcinoma.
|
N Engl J Med
|
2012
|
2.82
|
|
4
|
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
|
Hypertension
|
2012
|
2.31
|
|
5
|
The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease.
|
Kidney Int
|
2008
|
1.94
|
|
6
|
11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
|
J Clin Endocrinol Metab
|
2002
|
1.68
|
|
7
|
Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies.
|
Eur J Endocrinol
|
2009
|
1.65
|
|
8
|
Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.
|
Eur J Endocrinol
|
2012
|
1.47
|
|
9
|
The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry.
|
Dtsch Arztebl Int
|
2009
|
1.46
|
|
10
|
Deficits in the management of patients with adrenocortical carcinoma in Germany.
|
Dtsch Arztebl Int
|
2010
|
1.44
|
|
11
|
Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis.
|
J Clin Endocrinol Metab
|
2007
|
1.42
|
|
12
|
Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation.
|
Kidney Int
|
2008
|
1.36
|
|
13
|
The role of surgery in the management of recurrent adrenocortical carcinoma.
|
J Clin Endocrinol Metab
|
2012
|
1.29
|
|
14
|
Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients.
|
Am J Med Sci
|
2010
|
1.26
|
|
15
|
The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.
|
J Clin Endocrinol Metab
|
2012
|
1.23
|
|
16
|
High prevalence of reduced fecundity in men with congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
2009
|
1.17
|
|
17
|
Adrenal venous sampling: evaluation of the German Conn's registry.
|
Hypertension
|
2011
|
1.15
|
|
18
|
High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study.
|
J Clin Endocrinol Metab
|
2014
|
1.14
|
|
19
|
Risk factors associated with a low glomerular filtration rate in primary aldosteronism.
|
J Clin Endocrinol Metab
|
2008
|
1.08
|
|
20
|
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
|
J Clin Endocrinol Metab
|
2015
|
1.07
|
|
21
|
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
|
J Clin Endocrinol Metab
|
2010
|
1.07
|
|
22
|
Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe.
|
Eur J Endocrinol
|
2013
|
1.04
|
|
23
|
Observational study mortality in treated primary aldosteronism: the German Conn's registry.
|
Hypertension
|
2012
|
1.04
|
|
24
|
TP53 germline mutations in adult patients with adrenocortical carcinoma.
|
J Clin Endocrinol Metab
|
2011
|
1.04
|
|
25
|
Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens.
|
Eur J Endocrinol
|
2008
|
1.03
|
|
26
|
Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma.
|
Eur J Endocrinol
|
2009
|
1.02
|
|
27
|
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial.
|
J Clin Endocrinol Metab
|
2012
|
1.00
|
|
28
|
Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-β₁ in patients with chronic kidney disease.
|
Nephron Clin Pract
|
2011
|
1.00
|
|
29
|
Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy.
|
J Clin Endocrinol Metab
|
2012
|
0.99
|
|
30
|
Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency.
|
J Clin Endocrinol Metab
|
2010
|
0.99
|
|
31
|
Testosterone and blood pressure regulation.
|
Kidney Blood Press Res
|
2008
|
0.98
|
|
32
|
Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcome.
|
Mod Pathol
|
2010
|
0.98
|
|
33
|
Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
|
Clin Endocrinol (Oxf)
|
2010
|
0.98
|
|
34
|
Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.
|
J Clin Endocrinol Metab
|
2014
|
0.97
|
|
35
|
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
|
J Clin Endocrinol Metab
|
2014
|
0.97
|
|
36
|
Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy.
|
Clin Endocrinol (Oxf)
|
2014
|
0.96
|
|
37
|
Cushing's syndrome due to ACTH-secreting pheochromocytoma.
|
Can J Urol
|
2008
|
0.95
|
|
38
|
Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests.
|
J Clin Endocrinol Metab
|
2011
|
0.94
|
|
39
|
Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency.
|
Clin Endocrinol (Oxf)
|
2011
|
0.94
|
|
40
|
Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
|
J Clin Psychopharmacol
|
2008
|
0.93
|
|
41
|
Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism.
|
J Clin Endocrinol Metab
|
2014
|
0.92
|
|
42
|
Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature.
|
Eur J Endocrinol
|
2007
|
0.91
|
|
43
|
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma.
|
Eur J Endocrinol
|
2009
|
0.90
|
|
44
|
Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R.
|
Endocrinology
|
2007
|
0.89
|
|
45
|
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement.
|
J Clin Endocrinol Metab
|
2012
|
0.89
|
|
46
|
European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
|
BMC Endocr Disord
|
2014
|
0.88
|
|
47
|
Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency.
|
J Clin Endocrinol Metab
|
2010
|
0.87
|
|
48
|
Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency.
|
Eur J Endocrinol
|
2012
|
0.86
|
|
49
|
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma.
|
Clin Endocrinol (Oxf)
|
2011
|
0.86
|
|
50
|
Apparent mineralocorticoid excess syndrome: an overview.
|
Arq Bras Endocrinol Metabol
|
2005
|
0.84
|
|
51
|
Glucocorticoid-related signaling effects in vascular smooth muscle cells.
|
Hypertension
|
2008
|
0.84
|
|
52
|
[Diagnosis of primary hyperaldosteronism].
|
Med Klin (Munich)
|
2007
|
0.83
|
|
53
|
Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
|
Curr Med Res Opin
|
2014
|
0.82
|
|
54
|
Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
|
Clin Endocrinol (Oxf)
|
2009
|
0.81
|
|
55
|
Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy.
|
J Clin Endocrinol Metab
|
2014
|
0.80
|
|
56
|
Downregulation of hepatic glucose-6-phosphatase-α in patients with hepatic steatosis.
|
Obesity (Silver Spring)
|
2011
|
0.80
|
|
57
|
Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
|
Eur J Endocrinol
|
2007
|
0.78
|
|
58
|
Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma.
|
Eur J Endocrinol
|
2014
|
0.78
|
|
59
|
[Arterial hypertension and subclinical Cushing's syndrome].
|
MMW Fortschr Med
|
2010
|
0.78
|
|
60
|
Improved detection of hepatic metastases of adrenocortical cancer by contrast-enhanced ultrasound.
|
Oncol Rep
|
2008
|
0.77
|
|
61
|
BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
|
Clin Endocrinol (Oxf)
|
2013
|
0.77
|
|
62
|
Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
|
Eur J Endocrinol
|
2013
|
0.77
|
|
63
|
Sex steroid metabolism in human peripheral blood mononuclear cells changes with aging.
|
J Clin Endocrinol Metab
|
2005
|
0.77
|
|
64
|
IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease.
|
Growth Horm IGF Res
|
2009
|
0.77
|
|
65
|
Improvement of health-related quality of life in adult women with 21-hydroxylase deficiency over a seven-year period.
|
Endocr J
|
2012
|
0.77
|
|
66
|
Renal PPARγ mRNA expression increases with impairment of renal function in patients with chronic kidney disease.
|
Nephrology (Carlton)
|
2010
|
0.77
|
|
67
|
The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism.
|
J Hypertens
|
2016
|
0.77
|
|
68
|
Timelines in the management of adrenal crisis - targets, limits and reality.
|
Clin Endocrinol (Oxf)
|
2014
|
0.76
|
|
69
|
MR blockade in patients with chronic renal disease--not the more the merrier, but the earlier the better.
|
Nephrol Dial Transplant
|
2006
|
0.76
|
|
70
|
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism.
|
JCI Insight
|
2017
|
0.75
|
|
71
|
In reply.
|
Dtsch Arztebl Int
|
2014
|
0.75
|
|
72
|
The hypertensiogenetic steroid 19-nor-progesterone does not influence cortisol inactivation by 11beta-hydroxysteroid dehydrogenase type 2.
|
Clin Exp Hypertens
|
2009
|
0.75
|
|
73
|
[Primary hyperaldosteronism--more common than previously thought].
|
MMW Fortschr Med
|
2010
|
0.75
|
|
74
|
Is there sufficient evidence to consider the use of 11β-hydroxysteroid dehydrogenase type 1 inhibition in children?
|
Clin Endocrinol (Oxf)
|
2012
|
0.75
|
|
75
|
Reply.
|
J Hypertens
|
2017
|
0.75
|
|
76
|
Flutamide increases aldosterone levels in gonadectomized male but not female Wistar rats.
|
Am J Hypertens
|
2012
|
0.75
|
|
77
|
The Role of Fludrocortisone in Cognition and Mood in Patients with Primary Adrenal Insufficiency (Addison's Disease).
|
Neuroendocrinology
|
2015
|
0.75
|